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Summary 
 
Immune sensing of Mycobacterium tuberculosis relies on recognition by macrophages. 
Mycobacterial cord factor, trehalose-6,6’-dimycolate (TDM), is the most abundant cell wall 
glycolipid and binds to the C-type lectin receptor (CLR) MINCLE. To explore the kinase 
signaling linking the TDM-MINCLE interaction to gene expression, we employed quantitative 
phosphoproteome analysis. TDM caused upregulation of 6.7% and suppressed 3.8% of the 
14,000 phospho-sites identified on 3727 proteins. MINCLE-dependent phosphorylation was 
observed for canonical players of CLR signaling (e.g. PLC?, PKC?), and was enriched for 
PKC? and GSK3 kinase motifs. MINCLE-dependent activation of the PI3K-AKT-GSK3 
pathway contributed to inflammatory gene expression and required the PI3K regulatory 
subunit p85?. Unexpectedly, a substantial fraction of TDM-induced phosphorylation was 
MINCLE-independent, a finding paralleled by transcriptome data. Bioinformatics analysis of 
both datasets concurred in the requirement for MINCLE for innate immune response 
pathways and processes. In contrast, MINCLE-independent phosphorylation and 
transcriptome responses were linked to cell cycle regulation. Collectively, our global analyses 
show substantial reprogramming of macrophages by TDM and reveal a dichotomy of 
MINCLE-dependent and -independent signaling linked to distinct biological responses.      
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Introduction 
 
Macrophages play a dual role in tuberculosis, because they harbor the intracellular 
Mycobacterium (M.) tuberculosis in the phagosome, but also initiate the successful immune 
response by production of chemokines and cytokines. Recognition of mycobacteria by 
macrophages depends on the presence of pattern recognition receptors of the Toll-like 
receptor (TLR) and C-type lectin receptor (CLR) families, and their interaction with 
mycobacterial ligands derived from the cell wall or mycobacterial nucleic acids. TLR2 
recognizes the 19 kDa lipoprotein and Lipoarabinomannan (LAM) (1), whereas TLR9 is 
activated by mycobacterial DNA containing unmethylated CpG motifs (2, 3). Several SYK-
coupled activating CLR contribute to the macrophage response to mycobacteria, including 
Dectin-1 (4, 5), Dectin-2 binding manLAM (6), DCAR as a receptor for phosphatidyl-inositol 
mannosides (7), and MINCLE and MCL, which are receptors for the mycobacterial cord 
factor (8-11). The cord factor, trehalose-6,6’-dimycolate (TDM), is the major cell wall 
glycolipid and is per se sufficient to elicit several hallmarks of the mycobacteria-host 
interaction, i.e. inflammatory gene expression in macrophages, adjuvant activity towards 
Th1/Th17 responses, and granuloma formation in vivo (8, 12-14). TDM, and its synthetic 
glycolipid analog trehalose-6,6’-dibehenate (TDB), directly bind to MINCLE, and with lesser 
affinity to MCL (9). MINCLE-deficiency in macrophages and mice abrogates TDM-induced 
cytokine production, adjuvanticity and granuloma formation (8, 10, 15).     
 
The transcriptional responses induced by ligation of TLR or CLR family members are 
overlapping, as may be expected based on their similarity in function as pattern recognition 
receptors, and include expression of pro-inflammatory chemokines and cytokines. However, 
there are also distinct response patterns linked to specific biological responses (16). For 
example, the TLR9 ligand CpG DNA induces high level IL-12 production and thereby 
provides a strong signal for Th1 differentiation. In contrast, the CLR ligands Curdlan (via 
DECTIN-1) and TDB (via MINCLE) induce robust Th17-type CD4+ T cell responses through 
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production of IL-1? and IL-23 (10, 14, 15, 17). These distinct gene expression patterns of 
macrophages stimulated with ligands for either TLR or CLR can be attributed to the 
differences in signal transduction pathways between both receptor families. TLR signaling is 
dependent on the adapter protein MYD88 (engaged by all TLR except TLR3) and/or TRIF 
(engaged by TLR3 and TLR4), the kinases IRAK4 and TBK1, and the E3 ligase TRAF6, to 
activate the transcription factors NF-?B and Interferon regulatory factors (IRF) (reviewed in 
(18)). TLR signaling has been intensely investigated in the last 15 years, including several 
proteomic and phosphoproteomic studies, revealing new kinases and signaling modules 
relevant for the transcriptional response to TLR ligands (19-21).  
 
Activating CLR share signaling through an ITAM motif and the kinase SYK (22). Dectin-1 
directly recruits SYK via a hemi-ITAM motif (23), whereas MCL, MINCLE and DECTIN-2 
associate with the ITAM-containing FcR? chain to activate SYK (16). Downstream of SYK, 
activation of PLC?2, phosphorylation of PKC??(24), and assembly of the CARD9-BCL10-
MALT1 complex is required for activation of NF-?B (25). PLC?2 also triggers activation of the 
transcription factor NFAT and induces expression of EGR family members (26). However, in 
contrast to the TLR family, the signaling cascades downstream of SYK-coupled CLR have 
not been systematically studied using unbiased global proteomic and transcriptomic 
approaches.    
Rapid signal transduction from pattern recognition receptors located at the cell membrane to 
the nucleus relies on multiple forms of post-translational modification (PTM) of proteins, 
altering the localization, interaction with other proteins, enzymatic activity or stability of the 
substrate proteins. Together with ubiquitination and acetylation, kinase-mediated 
phosphorylation is one of the best characterized molecular switches in cellular signaling (27). 
In CLR-induced macrophage activation, reversible phosphorylation regulated by kinases and 
phosphatases likely plays an essential role, as evidenced by the essential function of the 
kinases SYK and PKC?, or the activation of the MAPK module, which lead to activation of 
transcription factors and thereby induce inflammatory gene expression. A comprehensive 
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analysis of the changes in protein phosphorylation in response of macrophages to 
stimulation through a SYK-coupled CLR has not been reported yet. It is therefore unknown 
which kinases, transcription factors and other signaling proteins in addition to the above 
mentioned players are regulated by phosphorylation in response to CLR stimulation in 
macrophages.     
 
Here, we investigated global phosphorylation of proteins in macrophages of wild type and 
MINCLE-deficient mice in response to stimulation with TDM to obtain new insight into the 
signaling and biological processes regulated through phosphorylation. To determine to which 
extent TDM-triggered protein phosphorylation is initiated through its receptor MINCLE, we 
compared TDM-stimulated wild type and Mincle-deficient macrophages. While the 
phosphorylation of many canonical kinases in the SYK-CARD9 pathway was induced in a 
MINCLE-dependent manner, we observed a surprisingly large extent of MINCLE-
independent protein phosphorylation. To investigate whether gene expression induced by 
TDM depends entirely on its receptor MINCLE, RNAseq analysis was performed. Consistent 
with the phosphoproteomic data, RNAseq analysis showed that a substantial fraction of the 
transcriptional response was at least partially independent of MINCLE. These MINCLE-
independent changes in phosphorylation and gene expression were associated with cell 
cycle regulation and metabolic changes, whereas MINCLE was required for signaling and 
transcription programs linked to cytokine production and innate immune response. Since 
activation of the PI3K-AKT-GSK3 axis was MINCLE-dependent, we employed macrophages 
deficient in the PI3K regulatory subunit p85? and observed a significant contribution of this 
pathway to the production of cytokines by cord factor-activated macrophages.           
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Experimental procedures 
 
Mice and macrophage differentiation 
C57BL/6 and Mincle-/- mice (originally provided by the Consortium of Functional Glycomics) 
were bred at the animal facility of the Medical Faculty in Erlangen. PI3K p85α-deficient mice 
(28) were provided by Dr. Gernot Schabbauer. Msr1-/- mice were provided by Dr. Matthias 
Trost, Fyb-/- mice by Dr. Annegret Reinhold, C5aR1-/- mice by Dr. Markus Bosmann, and 
p110?,?-/- mice (29) by Dr. Sandra Beer-Hammer. All mice were created on or backcrossed to 
a C57BL/6 background. Bone marrow cells were isolated and after erythrocyte lysis cultured 
in cDMEM supplemented with 10% FCS, 1% penicillin/streptomycin (Sigma Aldrich), 50 μM 
β-mercaptoethanol and 10% (v/v) M-CSF containing L cell conditioned medium (LCCM) for 7 
days. After overnight depletion of adherent cells, 5 to 6 x 106 of the non-adherent cells were 
seeded per 10 cm petri dish. On day 3, 5 ml cDMEM + 10 % LCCM were added, and 
differentiated bone marrow macrophages (BMM) were harvested on day 7. 
Stimulation, cell lysis and phosphopeptide preparation 
The glycolipid compounds TDM (Bioclot, Aidenbach, Germany) and TDB (Avanti Polar 
Lipids, Alabaster, USA) were used in a plate-bound form. For coating onto tissue culture 
plates, TDM/TDB were dissolved in isopropanol (ISO) by incubation at 60°C for several 
minutes and added to cell culture plates. ISO was evaporated by incubation at room 
temperature in a biological safety cabinet for several hours. TDM and TDB were used at 2 
μg/ml or 5 μg/ml.  Trehalose monoester (TMX) and diester (TDX) glycolipids containing C12 
and C16 acyl chains were synthetized and purified as previously described (30) and coated 
for stimulation of macrophages at a concentration of 2 μg/ml as described above for TDM 
and TDB. Control ligands 0.5 μM CpG (TIB Molbiol) and 20 ng/ml LPS (Escherichia coli 
055:B5; Sigma Aldrich) were diluted in cDMEM. Overnight pre-stimulation of macrophages 
with 10 ng/ml LPS was performed in petri dishes. The pharmacological AKT inhibitors 
Triciribine (5 μM) and AKT-Inhibitor VIII (10 μM; MERCK Millipore) as well as the PI3K p110 
isoform-specific inhibitors PIK-75 (1 μM; Selleckchem) and TGX-221 (1 μM; Selleckchem) 
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and the PI3K inhibitor LY294002 (20 μM, EMD Millipore) were simultaneously added to the 
stimulation. 
For phosphoproteome analysis 50 x 106 cells per sample were stimulated for 45 minutes. 
After washing cells with cold PBS, macrophages were harvested in PBS containing protease 
and phosphatase inhibitors (1:50 Roche Complete (50x); 1:50 NaF (0.5 M); 1:100 β-
Glycerophosphat (1M); 1:200 Na3VO4 (200 mM)). The samples were centrifuged for 5 min, 
1400 rpm at 4°C and the pellets were lysed with 100 to 200 μl lysis buffer (1% Rapigest, 50 
mM Tris pH8,0, 1 mM TCEP). Afterwards, 1 μl Benzonase was added.  
 
pY immunoprecipitation 
After stimulation, cells were lysed witch RIPA buffer containing proteinase and phosphatase 
inhibitors (Roche complete, 0.5 M sodium fluoride, 1 M β-glycerophosphate, 200 mM sodium 
orthovanadate). Cell lysates were sonicated and protein concentrations were assessed. 
Afterwards 500 μg protein were incubated with Pure Proteome Protein G Magnetic Beads 
(MERCK Millipore) decorated with 4G10 anti-phospho Tyrosine antibody overnight. After 
removing the supernatant and washing the beads, the phosphoproteins on the beads were 
reduced with Dithiotreitol and alkylated with Iodoacetamide. The proteins were digested with 
Trypsin (Pierce). Supernatants were collected, centrifuged (20.000xg, 20 min, 4°C), dried in 
the Speedvac and analysed by LC-MS. 
 
Experimental Design and Statistical Rationale 
For the phosphoproteome analysis, we used LPS-primed macrophages from WT and 
MINCLE-deficient mice and stimulated them with plate-coated TDM or ISO solvent control for 
45 min. Three completely independent experiments were performed for macrophage 
differentiation and stimulation, thus a samples size of three biological replicates was used. 
After cell lysis the proteins were reduced, alkylated and digested with trypsin. Then the 
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peptide samples from experimental conditions to be directly compared (WT_TDM vs. 
WT_ISO; and WT_TDM vs. Mincle-/-_TDM) were labeled with light or heavy formaldehyde 
and mixed together before further processing. Phosphopeptides were fractionated and 
enriched by HILIC and titanium-dioxide beads, and analyzed by LC-MS/MS. Log2 ratios of 
each protein/condition were calculated for the three independent experiments. Quantified 
mass spectrometry data was statistically analysed using a two-tailed student’s t-test in 
Perseus v1.5.1.1 (31) as data was normally distributed. Phosphopeptides were considered 
significantly regulated if the following conditions were met: p<0.05, ?log2(fold 
change)?>0.58).  
 
Mass spectrometric analysis 
Protein amounts of lysates from three biological replicates of each WT and Mincle-/- 
macrophages treated with plate-coated TDM or cultured in solvent-treated control wells (ISO) 
were determined by EZQ protein assay (Pierce). An equivalent of 4 mg of protein per 
replicate was reduced (10 mM TCEP, 30 min, 56?C) and alkylated (10 mM Iodoacetamide, 
30 min, at RT in dark) prior to trypsin digestion (Worthington, Trypsin TPCK treated) using a 
ratio 1:100 for 3 hrs and a second digestion with same ratio overnight. Peptides were 
desalted via C18Sep-Pak SPE (Waters) and dried under vacuum centrifugation. 
Peptides samples were re-suspended in 100 ?L of 100 mM TEAB and dimethyl labelled (32) 
as follows: WT-ISO and Mincle-/--TDM were labelled with the light isotope-coded chemicals 
(12CH2O and NaBH3CN) while the intermediate isotope-coded dimethyl chemicals (12CD2O 
and NaBH3CN) was used for the labelling of WT-TDM samples. The chemical reaction was 
quenched by the addition of 1% ammonium hydroxide and further neutralized by the addition 
of 50% TFA. Labelled peptides were desalted via C18 Sep-Pak SPE (Waters) and dried 
under vacuum centrifugation and analyzed individually by LC-MS/MS to ensure > 95% 
labelling efficiency. The three different conditions were combined in 1:1 ratio as follows, WT-
TDM (Intermediate) vs. WT-ISO (light) and WT-TDM (intermediate) vs. Mincle-/--TDM (light), 
and subjected to fractionation by hydrophilic interaction liquid chromatography (HILIC) (33). 
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Peptides were collected in 13 fractions and subjected to phosphopeptide enrichment using 
TiO2 spin columns before LC-MS/MS analysis (34-36). 
Dimethyl-labelled samples were separated on an Ultimate 3000 Rapid Separation LC 
Systems chromatography (Thermo-Fisher Scientific) with a C18 PepMap, serving as a 
trapping column (2 cm x 100 μm ID, PepMap C18, 5 μm particles, 100 Å pore size) followed 
by a 50 cm EASY-Spray column (50 cm x 75 μm ID, PepMap C18, 2 μm particles, 100 Å 
pore size)(Thermo-Fisher Scientific) with a linear gradient consisting of 2.4-28% (ACN, 0.1% 
formic acid (FA)) over 120 min at 300 nl/min. Mass spectrometric identification was 
performed on an Orbitrap Fusion Tribrid mass spectrometer (Thermo-Fisher Scientific) 
operated in data-dependent, positive ion mode similar to previously published (35, 37). 
FullScan spectra were acquired in a range from 400 m/z to 1500 m/z, at a resolution of 
120,000, with an automated gain control (AGC) of 300,000 ions and a maximum injection 
time of 50 ms. HCD fragmentation was performed at 33% collision energy for all included 
precursor ions and MS/MS fragments were detected in the linear ion trap mass analyzer in 
rapid mode.  
Protein identification and quantification were performed using MaxQuant Version 1.5.3.17 
(38) with the following parameters: stable modification carbamidomethyl (C); variable 
modifications phosphorylation (STY), oxidation (M), acetylation (protein N terminus), 
deamidation (NQ), hydroxyproline (P), quantitation labels Dimethyl and Dimethyl:2H4 on N-
terminal and/or lysine, and trypsin as enzyme with 2 missed cleavages. Search was 
conducted using the Uniprot-Trembl Mouse database (55,505 entries, downloaded 
September 28th, 2015), including common contaminants. Mass accuracy was set to 4.5 ppm 
for precursor ions and 0.5 Da for ion trap MS/MS data. Identifications were filtered at a 1% 
false-discovery rate (FDR) at the protein level, accepting a minimum peptide length of 5 
amino acids. Quantification of identified proteins referred to razor and unique peptides and 
required a minimum ratio count of 2. Dimethyl-based relative ratios were extracted for each 
protein/conditions and were used for downstream analyses.  
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Next generation sequencing 
For RNAseq analysis 0.5x106 BMM were stimulated with 2 μg/ml plate-coated TDM or 
evaporated isopropanol as solvent control for 24 hours. Total RNA was then isolated using 
the PeqGold RNA Micro Kit (Peqlab Biotechnology GmbH, Erlangen, Germany) according to 
the manufacturer’s guidelines. RNAs were stored at -80°C and sent to the Next Generation 
Sequencing Core Unit of the University Hospital Erlangen for RNA sequencing. Quality and 
integrity of the isolated RNAs was confirmed by the Agilent 2100 Bioanalyzer (Agilent 
Technologies, Waldbrunn, Germany) with all RNAs having RIN> 8.5. RNAseq library 
preparation was done with pooled technical replicates using the TruSeq stranded mRNA 
Library Prep Kit (Illumina, Inc.) and sequencing was performed on the Illumina HiSeq 2500 
platform (100 bp single-end) (Illumina, Inc.). Trimmed sequencing reads were aligned to the 
Mus musculus reference genome GRCm38 using the RNA-seq aligner STAR (version 
2.5.3a) (39). For gene level quantification the software package Salmon (40) was used. Data 
normalization (TMM, edgeR, Bioconductor R-package) and statistical analysis for 
identification of differentially expressed genes were performed using the limma Bioconductor 
R-package (41). Due to consistent sequencing depth across all RNA samples, limma-trend 
was used for differential expression analysis. Based on a classical interaction model, 
differentially expressed genes were determined according to the following criteria: adjusted 
(Benjamini-Hochberg) p-value < 0.05, |log2 fold-change| > 1. Gene ontology (GO) analyzes 
were performed using Cytoscape BiNGO (Cytoscape version 3.5.1) (42) (Benjamini-
Hochberg false discovery rate (FDR) correction p-value <0.05 and hypergenomic 
distribution). For pathway enrichment analysis the InnateDB (http://www.innatedb.com) 
analysis platform was used (Benjamini-Hochberg (FDR) correction p-value <0.05 and 
hypergenomic distribution). 
 
Bioinformatic analysis 
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Hierarchical clustering and visualization of regulated phosphopeptides in WT and Mincle-/- 
macrophages by TDM was done in a heatmap and histogram using GProX Version 1.1.13, 
(43). To define sets of MINCLE-dependently and -independently regulated phosphorylation 
sites, the following parameters were used: MINCLE-dependent phosphorylation sites (TDM 
vs. ISO: fold change ≥ 1.5; p ≤ 0.05 and WT vs. Mincle-/- fold change ≥ 1.5) and MINCLE-
independent phosphorylation sites (TDM vs. ISO: fold change ≥ 1.5; p ≤ 0.05 and WT vs, 
Mincle-/- fold change ≤ 1.25). 
GO and pathway analysis 
Using innateDB (www.innateDB.com Version 5.4) the over-represented GO terms and 
pathways over the genomic background for MINCLE-dependent or -independent 
phosphorylation sites were analyzed (hypergeometric distribution and Benjamini-Hochberg 
FDR). Additionally, to compare TDM-induced phosphoproteins to a reference list containing 
all phosphoproteins detected in our experiment, the odds ratio ((number matches list A / 
number non-matches list A) / (number matches list B / number non-matches list B)) and 
Fisher’s exact probability were calculated for each GO term and pathway. Only GO terms 
with at least 4 and pathways with at least 5 identified phosphoproteins were accepted. As 
cutoff an odds ratio ≥ 1.3 and a corrected p-value ≤ 0.05 were used. 
Kinase motifs 
Phosphorylation sites were analyzed for over-represented kinase motifs using motif-x (motif-
x.med.harvard.edu, Version 1.2 10.05.06). MINCLE-dependent or independent 
phosphorylation sites were analyzed vs. our own reference list containing all phosphorylation 
sites detected in at least 2 replicates (7436 peptides). The following parameters were used: 
width = 13; occurrences = 10; significance 0.002. 
 
Western blot 
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For Western blot analysis, cellular lysates were prepared in RIPA buffer containing 
proteinase and phosphatase inhibitors (Roche complete, 0.5 M sodium fluoride, 1 M β-
glycerophosphate, 200 mM sodium orthovanadate). Western blot was performed by 12%-
SDS-PAGE and wet-blotting. The following Abs were used: anti-pSYK (Tyr525/526), anti-SYK, 
anti-pERK (Thr202/Tyr204), anti-ERK1/2, anti-pAKT (Thr308), anti-pAKT (Ser473), anti-AKT, anti-
pGSK-3 (Ser9), anti-phospho-p38 (Thr180/Tyr182) and anti-p38 (Cell Signaling), anti-Mincle 
(clone 4A9, MBL), anti-phospho-Tyrosine 4G10 (MERCK Millipore), anti-α-Tubulin (Sigma 
Aldrich) and anti-GRB2 (BD) as loading control and HPR-conjugated secondary Abs 
(Jackson Immuno Research Laboratories). 
 
qRT-PCR 
Cellular lysates for quantitative RT-PCR were prepared with Trifast (Peqlab, Erlangen, 
Germany) to perform phenol/chloroform isolation according to manufacturer’s protocol. cDNA 
synthesis was done using the High Capacity cDNA Reverse Transcription Kit (Applied 
Biosystems). For qRT-PCR primers and probes (listed in Supplemental Table 3) were 
selected from the Universal Probe library (Roche) and purchased from Metabion. Hprt was 
used as housekeeping control and fold changes were calculated by the ΔΔCT method.  
 
Griess-assay and ELISA 
Nitrite and cytokine concentrations were analyzed in the supernatant of 200,000 cells in 96-
well plates (triplicates) after 48 h stimulation unless otherwise stated. Cytokine 
concentrations were determined by DuoSet Sandwich ELISA (R&D Systems) according to 
the manufacturer’s protocol. NO production was assessed by measuring nitrite levels with 
the Griess assay. 10 ng/ml IFN? (Peprotech) was used as costimulatory ligand for the Griess-
assay. 
 
Protein concentration 
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To quantitate the protein content, 200,000 cells per well in 96-well plates (triplicates) were 
lysed with RIPA buffer containing proteinase and phosphatase inhibitors (see WB) and 
protein concentrations were assessed by BCA Protein Assay Kit (Thermo Fisher) according 
to the manufacturer’s protocol. 
 
MTT conversion assay 
To quantitate macrophage content in the wells, a colorimetric assay measuring the activity of 
cellular NAD(P)H oxidoreductases as conversion of the tetrazolium dye MTT (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) was performed. MTT (20 μl of a 5 
mg/ml stock solution) was added to the cultures at the indicated time points. After 3 hours of 
incubation at 37oC, the formazan crystals formed were dissolved by addition of 150 μl of a 
10% SDS solution in HCl and incubation overnight. The OD570nm was then measured in an 
ELISA reader. 
 
Statistical analysis  
Statistical analyses were performed using Prism5 (GraphPad Software). Significance was 
determined by unpaired Mann-Whitney test for non-Gaussian distribution. * p ≤ 0.5, ** p ≤ 
0.01. 
 
Data availability 
Mass spectrometric raw data and the MaxQuant outputs are available through the PRIDE 
repository (https://www.ebi.ac.uk/pride/archive/) (44) and have been assigned the identifier 
PXD009513. Individual MS/MS spectra of phosphopeptides can be found here: 
http://msviewer.ucsf.edu/prospector/cgi-bin/mssearch.cgi?report_title=MS-
Viewer&search_key=dtftndgcpu&search_name=msviewer. 
RNAseq datasets have been submitted to Gene Expression Omnibus and will be available 
under accession number GSE115322.  
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Results 
 
Kinetics and MINCLE-dependence of TDM/TDB-induced SYK/MAPK activation and 
cytokine expression 
MINCLE expression is low in resting macrophages but induced by TLR and CLR stimuli. To 
achieve robust MINCLE expression, enabling a synchronized signaling response to MINCLE 
triggering, we primed bone marrow-derived macrophages (BMM) over night with a relatively 
low dose of LPS (10 ng/ml). Stimulation with the cord factor trehalose-6,6’-dimycolate (TDM) 
or the synthetic glycolipid adjuvant trehalose-6,6’-dibehenate (TDB), both used in plate-
coated form, triggered robust phosphorylation of SYK and of the MAPK ERK1/2 and p38, 
peaking between 40’ and 120’ after stimulation (Fig. 1A, B). Production of the cytokines G-
CSF and TNF in response to TDM/TDB stimulation was detectable first after 120’ (G-CSF) 
and 60’ (TNF) (Fig. 1C, D). Confirming previous results (10, 45), kinase activation and 
cytokine production were almost completely MINCLE-dependent (Fig. 1).  Activation of SYK 
and MAPK preceded expression and secretion of cytokines: between 40’ to 60’ after 
stimulation, we observed strong protein phosphorylation but no cytokine secretion. Thus, we 
decided to use this time window for unbiased phosphoproteome analysis, when changes in 
phosphorylation are likely directly induced by interaction of TDM with its receptor and not 
influenced by secondary effects of secreted cytokines.       
 
Unbiased detection of TDM-induced protein phosphorylation  
Ligand binding by MINCLE leads to tyrosine phosphorylation of the kinases SYK and PKC? 
(24, 45, 46). We therefore first used the antibody 4G10 to detect changes in tyrosine 
phosphorylation of proteins after macrophage stimulation by Western blot, which revealed 
several differential bands in response to the MINCLE ligands TDB/TDM and the TLR9 ligand 
CpG ODN, respectively (Suppl. Fig. S1A). Mass spectrometry analysis of 4G10-enriched 
immunoprecipitation samples obtained 20’ and 60’ after stimulation with TDB was then used 
to identify tyrosine-phosphorylated proteins (Suppl. Fig. S1B). A total of 42 tyrosine-
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phosphorylated proteins were detected in two independent experiments (Suppl. Table S1), 
among them the established MINCLE-signaling protein PKC?, the PI3K regulatory subunit 4 
(Pik3r4, aka VPS15), and GSK-3, consistent with activation of the PI3K-AKT-GSK3 signaling 
pathway; the small GTPase RAB22a, shown to be recruited to phagosomes; and the cell 
cycle-associated proteins PRP4 and RBM14 (Suppl. Fig. S1C). 
Tyrosine phosphorylation constitutes only a small fraction of cellular protein phosphorylation, 
whereas phosphorylation of serine and threonine residues accounts for the vast majority of 
protein kinase substrates. To globally detect protein phosphorylation on serine, threonine 
and tyrosine residues in a quantitative manner, we employed a protocol combining dimethyl 
labeling of cell lysates, enrichment of phosphopeptides by HILIC and titanium dioxide beads, 
and LC-MS/MS (Fig. 2A). In three independent experiments, we identified a total of 14173 
phosphopeptides from 3727 phosphoproteins (Fig. 2B; Suppl. Table S2). In accordance with 
previous work in LPS-stimulated BMM (21), the vast majority of phosphorylated amino acids 
were serine (83%) and threonine (14%) residues, and only 3.4% of all sites were phospho-
tyrosines (Fig. 2C). Treatment of WT macrophages with TDM significantly (1.5-fold, p<0.05) 
upregulated 846 (6.7%) and suppressed 484 (3.8%) of all phosphopeptides (Fig. 2D, left 
panel), whereas the comparison of WT and MINCLE-deficient TDM-stimulated macrophages 
showed 641 (5.5%) induced and 388 (3.4%) reduced phosphopeptides (Fig. 2D, right panel). 
Given the similar extent of regulation in these comparisons, we next determined whether 
TDM-induced regulation is MINCLE-dependent.      
 
MINCLE-dependence of TDM-induced protein phosphorylation   
The 1330 phosphopeptides significantly regulated by TDM in WT macrophages were 
analyzed by hierarchical clustering and visualized using a heatmap representation to 
determine whether up- or down-regulation depended on Mincle (Fig. 3A). For a large fraction 
of these phosphopeptides, regulation was similar in both comparisons, indicating that TDM-
induced regulation was MINCLE-dependent (indicated by subgroups C1 and C5 in Fig. 3A). 
However, a substantial portion of TDM-regulated phosphopeptides did not differ between WT 
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and MINCLE-deficient macrophages or were even regulated more strongly in the absence of 
MINCLE (subgroups C4 and C6 in Fig. 3A). Focussing on phosphopeptides induced by 
TDM-stimulation in WT macrophages, we used histogram plots to overlay the log2-fold 
change distribution of WT versus MINCLE-deficient TDM-stimulated macrophages, which 
revealed that indeed around half of all phosphopeptides upregulated by TDM were not 
significantly more abundant in WT than in MINCLE-deficient macrophages (Fig. 3B). To 
analyze whether MINCLE-dependent and –independent kinase pathways may be linked to 
distinct cellular components and biological responses to TDM stimulation, we performed 
bioinformatic analyses using the InnateDB Gene Ontology and Pathway enrichment analysis 
tools (Fig. 3C, D; Suppl. Table S3). Indeed, MINCLE-dependent phosphoproteins were 
associated with the GO terms “late endosome / lysosomal membrane”, “endoplasmic 
reticulum” and “cytoskeleton”, “innate immune response”, and with signaling pathways 
controlled by the adapter protein FcR? and by PLC, two canonical players of MINCLE-
signaling through SYK. In contrast, Mincle-independent phosphoproteins were enriched for 
the cellular components “early endosomal membrane” and “nuclear membrane”, for the 
biological processes or pathway terms “RNA splicing”, “chromatin organization/remodeling” 
and “cell cycle”.      
Next, we employed the algorithm motif-X to search for footprints of MINCLE-dependent and 
–independent kinase activation in the phosphopeptide dataset. The sets of significantly 
induced phosphopeptides were analyzed for enrichment compared to a reference set of 7436 
peptides detected in at least 2 experimental replicates (Suppl. Fig. S2). Mincle-dependent 
phosphopeptides showed the strongest enrichment for a novel LxSP motif, which has not 
been associated with a putative mammalian kinase yet, but was recently reported as a 
candidate substrate motif for the CMV-encoded kinase pUL97 (47). The substrate motifs of 
PKA and of PKC?, an established kinase in the MINCLE pathway linking SYK to CARD9 
phosphorylation (24), were enriched in the MINCLE-dependent set of phosphopeptides. In 
addition, a substrate motif for the kinase GSK-3, which was tyrosine-phosphorylated in 
response to TDB (Suppl. Fig. S1), was also detected in the MINCLE-dependent 
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phosphopeptide set. On the other hand, motif-X analysis of MINCLE-independently induced 
phosphopeptides yielded exclusively a motif for the DNA-damage kinases ATM/ATR, which 
was previously also found to be enriched in the phosphoproteome of macrophages activated 
through TLR4 by LPS (21).  
A graphical overview of the phosphoproteome dataset is provided in Fig. 4. First, we 
confirmed MINCLE-dependent phosphorylation of several established C-type lectin receptor 
signaling proteins, including the phospholipase PLC?2 and PKC?, which are upstream of the 
CARD9-BCL10-MALT1 complex; activation of the MAPK signaling module with 
phosphorylation of MEKK1 (MAP3K1), and ERK1 (MAPK3) and ERK2 (MAPK1). Next, we 
identified the Src-family kinases LYN and FYN, as well as the tyrosine kinase FES, as 
Mincle-dependent TDM-activated phosphoproteins. The serine/threonine kinase PRKD2, a 
downstream kinase mediating effects of PKC, has not been described in the Mincle-pathway 
yet. Several members of the NF-?B signaling module were detected as phosphoproteins, 
including IKBKB (IKK?), IKBKG (NEMO), and the transcription factors NFKB2 (p100), 
NFKBIE (I-?B?) and NFKBIZ (I-?B?). Although regulation of the phosphosites in these 
proteins did not pass our thresholds, a closer look at the data in Suppl. Table 2 indicated 
regulation of NF-?B signaling by TDM: phosphorylation of the kinase IKK? at Ser-672 was 
reduced 1.43-fold (p=0.03) and phosphorylation of the transcription factor NFKB2 at Ser-858 
was increased 1.52-fold (p=0.09). Consistent with the GO term enrichment of endosomal 
proteins, several transporters for chloride (CLCN3, CLCN7) and protons (ATP6V0A2, 
TCIRG1 (48)), the metalloreductase STEAP3 (49), and the endosomal GTPase RAB8A (50), 
were MINCLE-dependently phosphorylated in response to TDM, pointing to regulation of 
endosomal maturation and trafficking processes. The phosphorylation of 9 solute carrier 
proteins (SLC) suggests that MINCLE signaling may have a larger impact on the exchange 
of amino acids, sugars and other nutrients into and out of the cell, or between different 
macrophage compartments.  
With regard to Mincle-independent phosphorylation, the adapter proteins DAB2 and FYB, the 
tyrosine kinase HCK and the focal adhesion kinase PTK2 may be involved in the 
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phosphorylation of several cytoskeletal (MYOF, MARCKS), ribosomal (EIF4G1, EIF4H1) and 
nuclear proteins, such as LMNA and PCM1, the transcription factors ARNT and FOXN3, 
chromatin remodelers (MECP2, REST) and constituents of PML nuclear bodies (ATRX, 
SP100, SUMO1).  
Interestingly, several cell surface receptors were phosphorylated in response to TDM 
stimulation (including the scavenger receptor MSR1, the complement receptor C5aR1, the 
chemokine receptor CXCR4, and the cation channel TRPV2, raising the possibility of parallel 
signaling pathways triggered by TDM stimulation, which may account for at least some of the 
MINCLE-independent phosphorylation events. Macrophages from several knockout mouse 
lines (Msr1-/-, Fyb-/-, C5ar1-/-) were used to test whether these cell surface receptors and 
adapter proteins phosphorylated in response to TDM play an essential role for the signaling 
and cytokine production. No differences were observed in the extent of phosphorylation of 
SYK, AKT or ERK1/2, nor in the release of G-CSF, IL-6 or CCL2, in the absence of MSR1 
(Suppl. Fig. S3A, B), C5aR1 (Suppl. Fig. S4A, B) or the adapter FYB (Suppl. Fig. S5A, B).    
 
MINCLE-dependent activation of PI3K-AKT signaling by TDM        
Several phosphoproteins associated with PI3K-AKT signaling were detected in the phospho-
tyrosine and phosphoproteome datasets, including the regulatory PI3K subunit p85? 
(PIK3R1), AKT1/2, and its substrates AKT1s, TSC2 and GSK-3 (Fig. 4; Suppl. Fig. S1). 
Although AKT activation in response to TDB was recently reported (51), the canonical AKT 
phosphosites Thr308 and Ser473 were not detected in the proteomic datasets. We therefore 
analyzed AKT phosphorylation by immunoblot and observed that stimulation of LPS-primed 
macrophages with TDM and TDB, but not with the TLR9 ligand CpG, induced robust 
phosphorylation of AKT at Thr308 and Ser473 (Fig. 5A), which correlates with AKT kinase 
activity. Phosphorylation of AKT started 40’ after stimulation and was almost completely 
dependent on MINCLE (Fig. 5B). We next tested the functional importance of AKT activity by 
employing the inhibitors Triciribine and AKT-Inhibitor VIII, which both suppressed the 
production of G-CSF, whereas release of IL-6 and NO were not affected (Fig. 5C). 
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Phosphorylation of AKT in response to TDM was completely abrogated by treatment with the 
PI3K inhibitor LY294002, which also inhibited G-CSF production (Suppl. Fig. S6A-C). There 
are four isoforms of the class I PI3K catalytic subunit, of which p110? and p110? are mainly 
expressed in hematopoietic cells (52). Macrophages derived from p110?/? double-deficient 
mice responded with normal AKT phosphorylation and unaltered G-CSF production to TDM; 
in contrast, combined  treatment with inhibitors specific for p110? and p110? (PIK-75 and 
TGX-221, resp.) prevented AKT phosphorylation and G-CSF release in WT and p110?/?-
deficient macrophages (Suppl. Fig. S6D, E), suggesting that p110? and/or p110? are the 
catalytic isoforms responsible for phosphorylation of AKT and expression of G-CSF. The 
catalytic subunits p110?, ?, ? all associate with the regulatory subunit PIK3R1 (aka p85?) 
(Suppl. Fig. S6F), which stabilizes them and contains an SH2 domain for interaction with 
tyrosine phosphorylated proteins (52). Therefore, we employed p85?-/- macrophages as a 
genetic tool to probe the functional role of PI3K activation. In the absence of p85?, 
phosphorylation of AKT on Ser473 and on Thr308 was strongly reduced after TDM-
stimulation of LPS-primed and of resting macrophages (Fig. 5D). Phosphorylation of the AKT 
substrate GSK-3 at Ser9 was also reduced in non-primed p85?-/- macrophages (Fig. 5D). 
These signaling defects were selective, because phosphorylation of SYK and ERK1/2 was 
unaltered (not shown). Production of NO, G-CSF and IL-6 were all significantly reduced in 
p85?-/- macrophages (Fig. 5E).  mRNA expression of IL-6, but not of CCL2, was strongly 
attenuated in response to TDM stimulation in p85?-/- BMM; although the levels of IL-10 
detected in the supernatant were not altered (Fig. 5E), p85-deficient macrophages showed 
significantly reduced expression of IL-10 mRNA (Fig. 5F).                      
 
Transcriptome analysis of macrophage activation by TDM reveals MINCLE-dependent 
and -independent gene expression 
The unexpectedly prominent MINCLE-independent phosphorylation events prompted us to 
re-assess the notion that transcriptional activation of macrophages by TDM is entirely 
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dependent on MINCLE-signaling via FcR?-SYK-CARD9 (10, 45). WT and MINCLE-deficient 
macrophages stimulated for 24 h with TDM were analyzed by RNAseq using Illumina HiSeq. 
Hierarchical clustering of differentially expressed genes showed that resting WT and 
MINCLE-deficient macrophages clustered closely together. Stimulation with TDM caused 
substantial up- and downregulation of gene expression in WT macrophages, with subclusters 
of apparently MINCLE-dependent and –independent gene expression (Fig. 6A). This 
impression was confirmed by applying fold change filtering, with 211 clearly MINCLE-
dependent and 339 -independent TDM-induced genes (Fig. 6B). K-means clustering of TDM-
regulated genes (Suppl. Table S4) was then used (Fig. 6C) to define gene sets with a 
characteristic pattern of induction and MINCLE-dependence for further bioinformatics 
analysis (Fig. 6D, Suppl. Table S5 and S6). Clusters 1 and 8 contained the largely or partially 
MINCLE-dependently induced TDM target genes, which were enriched for pathway 
annotations of Interferon signaling, TLR- and NF-?B-signaling, and innate immune response. 
In contrast, MINCLE-independent gene expression (clusters 4 and 6) were associated with 
metabolic alterations (cholesterol biosynthesis, glycolysis, metabolism of lipids) and cell cycle 
regulation, respectively (Fig. 6C, D). Cluster 6 was also associated with “ATR activation”, 
consistent with the enrichment of the ATM/ATR kinase motif found in the set of 
phosphopeptides upregulated in a MINCLE-independent fashion by TDM (Suppl. Fig. S2). 
Together, the RNAseq dataset revealed a similar degree of MINCLE-independent responses 
as observed in the phosphoproteome dataset, supporting the notion that not all TDM-
triggered signaling is caused by binding to MINCLE. Moreover, while the transcriptomic and 
phosphoproteome dataset cannot be compared directly, bioinformatics analysis yielded a 
concordant enrichment of terms associated with innate immune response for the MINCLE-
dependent changes at the level of transcription and phosphoproteins. In contrast, the 
MINCLE-independent responses in both datasets were enriched for annotations linked to cell 
cycle regulation. 
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The MINCLE-independent TDM-induced expression programme is also upregulated by 
trehalose ester glycolipids not binding to Mincle  
To validate the findings from the RNAseq dataset, qRT-PCR analysis of samples from 
independent experiments was performed. As expected, induction of mRNA expression for G-
CSF and iNOS (belonging to the MINCLE-dependent clusters 1 and 8) was largely 
dependent on MINCLE (Fig. 7A). In contrast, the expression of the chemokine CCL22 and 
the chemokine receptor CCR1 (both contained in cluster 4) was partially (Fig. 7B), and of 
CCL2 and the NAPDH oxidase NOX1 (two cluster 6 genes) was largely MINCLE-
independent (Fig. 7C, D). To determine whether the MINCLE-independent response to TDM 
is indeed specific for the cord factor or can be caused more broadly by (glyco-)lipids, we 
tested a set of trehalose monoester (TMX) and diesters (TDX) with acyl chains of various 
length (C12 and C16). In previous work, we had observed that the trehalose diester form of 
C16 bound to MINCLE and triggered cytokine production form macrophages (53). Confirming 
our previous results, the trehalose diester of C16 (and TDM and TDB) strongly stimulated 
expression of Csf3 in a completely Mincle-dependent manner, whereas the C22 behenic acid 
alone, the C12 trehalose diester, and the C12 and C16 monoesters did not trigger Csf3 
mRNA expression (Fig. 7E) or G-CSF secretion (not shown). In contrast, the expression of 
the MINCLE-independent TDM-target genes Dusp5, Nox1, and Ccl2 was significantly up-
regulated not only by the MINCLE-ligands (TDM, TDB, trehalose diester of C16), but also by 
the C12 diester and the C12 and C16 monoesters, whereas behenic acid coating of the 
plates alone only weakly induced expression of these genes (Fig. 7F-H). Upregulation of 
Dusp5, Nox1 and Ccl2 was largely independent of MINCLE, with a partial reduction after 
TDM stimulation.  
 
The Mincle-independent response to TDM and related glycolipids is linked to 
macrophage survival or proliferation 
Since GO and pathway enrichment analysis revealed that cluster 6 was enriched for “cell 
cycle” and “DNA synthesis”, we validated the expression of the cluster 6 genes Myc, Ccne1, 
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Ccne2, and Chek1 by qRT-PCR and confirmed their MINCLE-independent induction after 
TDM stimulation (Fig. 8A). As observed for DUSP5, CCL2 and NOX1 (Fig. 7E-G), expression 
of these cell cycle-associated genes was not only upregulated in a MINCLE-independent 
manner by the cord factor, but to a similar extent also by synthetic trehalose diesters and 
monoesters of C12 and C16 fatty acids, and more weakly by behenic acid alone (Fig. 8A). 
Ccne1 and Ccne2 encode the cyclins E1 and E2, whose expression peaks in mid-G1 to early 
S-phase of the cell cycle (54). The proto-oncogene Myc encodes the E-box transcription 
factor MYC which is associated with proliferation and self-renewal of macrophages (55, 56). 
CHEK1 is activated by the DNA-damage response kinase ATR and contributes to p53-
dependent responses (57). We observed that macrophage cultures treated with TDM 
appeared much denser than control cells cultured in medium alone (Suppl. Fig. S7A). This 
effect was also observed with the trehalose monoester and diester glycolipids, and appeared 
to be partially MINCLE-independent (Suppl Fig. S7A). This impression was quantitatively 
confirmed by measuring the protein content of the macrophage cultures (Fig. 8B, C). Of note, 
when analyzed over time, the protein content of control cultures diminished, but stayed 
constant in the TDM-treated samples, suggesting that TDM prevented a loss of 
macrophages during starvation from growth factors, which was partially MINCLE-dependent 
after 48 h (Fig. 8B). Interestingly, the MINCLE-ligand glycolipids (TDM, TDB and the 
trehalose diester of C16) lead to a stronger enhancement of cellular protein content in the 
wells than the monoesters, and this difference was MINCLE-dependent (Suppl. Fig. S7B). As 
an additional method to quantitate effects of TDM on macrophage survival and proliferation, 
we employed the MTT conversion assay. First, the effect of TDM and TDB was comparable 
to the activity of the macrophage growth factor M-CSF (Suppl. Fig. S7C). MTT conversion 
after 48h was significantly increased by all glycolipids, but not by behenic acid, with the 
strongest effect observed for the MINCLE ligands (TDM, TDB and the trehalose diester of 
C16) (Fig. 8C). Similar to the changes in total protein content, the MTT conversion rates of 
the untreated macrophages decreased over time (see 24h time point in Suppl. Fig. S7D), 
suggesting that the glycolipids caused increased survival of macrophages through the 
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MINCLE-independent upregulation of cell cycle-associated genes after 24h and additional 
MINCLE-dependent effects at the later 48h time point (Fig. 8B, C).   
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Discussion 
Recognition of the mycobacterial cord factor TDM by the CLR Mincle and the key role of 
SYK-CARD9-BCL10-MALT1 signaling has been firmly established by genetic deletion in 
mice. Compared to the well-studied TLR signaling pathways, an unbiased analysis of the 
signaling and transcriptome response to activation of MINCLE, or of related SYK-coupled 
CLR, is missing. This manuscript provides the first global assessment of macrophage 
activation by the mycobacterial cord factor TDM at the phosphoproteome level, combined 
with a corresponding RNAseq-based transcriptomic dataset. Our results show substantial 
regulation of phosphopeptides in response to TDM, which was comparable in breadth with 
similar studies investigating the phosphoproteome of TLR-activated macrophages (21). We 
consider most of the changes in phosphopeptide abundance as a direct consequence of 
TDM-induced signaling, because at the early timepoint of 45 minutes after stimulation no 
secreted cytokines could be detected in the supernatant. Importantly, the comparison of WT 
and MINCLE-deficient macrophages in phosphoproteome and transcriptomic analysis 
allowed us to confirm the importance of the TDM-Mincle interaction, yet it also revealed an 
unexpectedly large fraction of MINCLE-independent changes, which are functionally 
separate from the Mincle-dependent responses. 
MINCLE-dependent phosphorylation included several canonical players of this pathway, 
such as PKC? and PLC?2, which was consistent with the enrichment of PKC? kinase motifs 
among the phosphopeptides induced by TDM in a MINCLE-dependent fashion. Since PKC? 
is required for formation of the CBM complex and subsequent activation of NF-?B (24), the 
strong enrichment of the pathway term “NF-?B activation” and the GO category 
“inflammatory response” among the cluster of MINCLE-dependent TDM target genes in our 
RNAseq data fits very well.  
Several Src-family kinases were activated by TDM-MINCLE, including FYN and LYN. Of 
interest in this context, LYN was very recently reported to directly interact with MINCLE after 
TDM stimulation and to attenuate its signaling by recruitment of SIRP1a and SHP1 (58). The 
25 
 
signaling via the Src kinase LYN was triggered by MINCLE-dependent activation of the 
integrin CD11b (58); thus, the detection of induced LYN phosphorylation in our dataset may 
indicate integrin activation as a regulatory pathway of the response to TDM.  
Triggering of PI3K-AKT signaling by mycobacterial cord factor or its synthetic analog has 
recently been described in human DC (51) and in human neutrophil-like HL-60 cells (59). 
While we detected phosphorylation of several PI3K-AKT-associated proteins, including 
AKT1/2 and the regulatory PI3K subunit p85, the canonical phosphopeptides indicating 
activated AKT (Thr308 and Ser473) were not found in the phosphoproteome dataset, but 
readily detected as upregulated by TDB/TDM using immunoblot analysis. Our further data on 
the role of the PI3K/AKT pathway in TDM-induced macrophage activation indicate that the 
PI3K catalytic subunit isoforms p110? and p110? are redundant in macrophages, whereas 
pharmacological inhibition of p110? and p110? was sufficient to completely block AKT 
phosphorylation and TDM-induced G-CSF and IL-6 production. While the lack of a 
phenotype in p110?/?-deficient macrophages was at first surprising, given reports that p110? 
is the main isoform activated by tyrosine-kinase linked receptors in T cells and innate 
immune cells (60), these findings are concordant with previous reports showing redundancy 
between different p110 isoforms (61) and demonstrating a function for p110? in 
macrophages (62). The regulatory PI3K subunit p85? binds p110?, p110? and p110? and 
therefore appears to play a broader role in PI3K activation (52). Indeed, our data obtained 
with p85?-/- macrophages showed a strong reduction of TDM-induced phosphorylation of 
AKT and of several cytokines (Fig. 8). Strongly attenuated phosphorylation of AKT in the 
absence of p85? was found previously in murine peritoneal macrophages stimulated with 
LPS (63), but has not been demonstrated after stimulation with a CLR ligand before.  In 
contrast to earlier reports showing a selective reduction of the anti-inflammatory IL-10 and 
reciprocal overproduction of IL-12 by p85?-/- DC after stimulation with LPS (28), in our 
system both pro- and anti-inflammatory responses were similarly affected by p85? deficiency 
(and also by pharmacological inhibition of PI3K catalytic subunits p110? and p110?). Of 
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note, Luyendyk et al. observed increased IL-6 and TNF production by p85?-deficient 
peritoneal macrophages stimulated with LPS (63). At present we do not know whether this 
discrepancy reflects a differential role of p85-PI3K signaling in macrophages versus DC, or 
rather points to differences in the regulation of TLR- and CLR-driven responses by PI3K.              
The functional annotation of Mincle-dependently regulated phosphoproteins showed strong 
enrichment for endo-/lysosomal and transport proteins (Figs. 3, 4), an effect we had not 
observed in our analysis of LPS-induced phosphoproteins (21). The strong phosphorylation 
observed for many solute carrier proteins may reflect ongoing signaling at the plasma 
membrane when macrophages are stimulated with plate-bound TDM as used here, whereas 
soluble ligands such as LPS could result in more rapid internalization and diversion of 
signalosomes to intracellular compartments. On the other hand, the strong MINCLE-
dependent phosphorylation of phagolysosomal proteins is of interest with regard to the 
intracellular mycobacterial life-style. Several of these phosphoproteins control phagosomal 
maturation or trafficking processes, suggesting that TDM-MINCLE signaling modulates the 
fate of the mycobacterial niche in macrophages. In fact, the proton pump TCRIRG1 (alias 
ATP6V0A3) is important for acidification of the mycobacterial phagolysosome (48, 64). The 
metalloreductase STEAP3 controls iron homeostasis in macrophages (49) but has not been 
implicated in the mycobacteria-macrophage interaction yet. The endosomal GTPase RAB8A 
recruits PI3K to regulate the signaling from endosomal TLRs (50), which is of special interest 
with regard to the activation of PI3K-AKT signaling by TDM discussed above.  
The robust MINCLE-independent kinase activation and transcriptional changes was a 
surprising result of our unbiased approach to macrophage reprogramming by the cord factor, 
given the strong MINCLE-dependence of TDM-induced inflammatory responses and 
adjuvant activity reported by us and others before (8, 10, 65). The availability of synthetic 
mono- and diesters of trehalose with fatty acids of various length (C12, C16) allowed us to 
test whether the MINCLE-independent responses to TDM may not be caused by a specific 
propensity of the cord factor itself, but rather by more generic features of glycolipids. The 
results demonstrated a clear separation in the capacity of the glycolipids to induce 
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inflammatory genes (e.g. Csf3) associated with MINCLE-dependent clusters 1 and 8 (Fig. 6), 
which required the diester form of C16, and the MINCLE-independent induction of genes 
associated with cluster 4 and 6 (Fig. 6), which was triggered also by the trehalose 
monoesters (which do not bind to MINCLE). This finding raises the question which alternative 
signaling mechanism(s) may be triggered by the cord factor and related glycolipids in 
macrophages. An obvious candidate is the close MINCLE relative MCL, which was identified 
as second cord factor receptor following the detection of residual transcriptional responses in 
Mincle-/- mice (9) and can form heterodimers with MINCLE (66, 67). Although we have not 
tested whether MCL is responsible for kinase activation and gene expression in the absence 
of MINCLE in our system, we consider this unlikely for two reasons: first, MINCLE-deficiency 
abrogates completely the activation of several canonical CLR pathway proteins (e.g. SYK, 
PKC?; ERK1/2) which would be shared by MCL signaling; second, the MINCLE-independent 
response appears to be functionally distinct based on the bioinformatic analysis of pathway 
and GO association of phosphoproteome and transcriptome changes. To confirm or reject 
this notion, MINCLE-independent phosphoprotein regulation and TDM target gene 
expression needs to be tested in macrophages treated with SYK-inhibitors and in FcR?-
deficient macrophages in future experiments. TLR/MYD88-dependent activation by the cord 
factor has been reported previously (12, 68), which could provide an alternative explanation 
for the MINCLE-independent signaling. While we have not tested this possibility by using 
Myd88-/- macrophages for analysis of MINCLE-independent target gene expression, the 
finding that pathway enrichment associated MYD88 signaling with the MINCLE-dependent 
response argues against this explanation. The scavenger receptors MARCO and MSR1 can 
also bind TDM (68); therefore, the phosphorylation of MSR1 prompted us to test its functional 
role in TDM-induced signaling and gene expression, but we did not observe differences in 
Msr1-/- macrophages. Finally, our attempts to assign a role in MINCLE-independent target 
gene expression to two other candidate phosphoproteins, the complement receptor C5aR1 
and the adapter protein FYB, were not successful. Activation of integrins by TDM may be 
another mechanism of MINCLE-independent signaling, and is supported by phosphorylation 
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of the kinases HCK and PTK2, both involved in integrin-signaling (69, 70). Importantly, 
receptor-independent mechanisms such as membrane alterations induced by TDM and 
related glycolipids encountered by macrophages should also be considered as potential 
cause of the MINCLE-independent phosphorylation events and transcriptional changes. 
Such direct interactions with membrane lipids and alterations in signaling molecule assembly 
have been described for urate acid crystals and aluminium hydroxide (71, 72).  
Regardless of whether MINCLE-independent phosphorylation and transcriptional regulation 
are induced by receptor-independent membrane alterations or triggered by a specific 
receptor of yet unknown identity, the type of biological processes and pathway terms 
associated with it were remarkably distinct. Especially prominent was the association of cell 
cycle-related genes and phosphoproteins that included regulators of the DNA-damage 
response like the kinase ATR. In turn, the only significantly enriched kinase motif identified in 
the MINCLE-independent phosphosites was the ATM/ATR motif. The MINCLE-independent 
upregulation of several cyclins and the pro-proliferative transcription factors MYC and of the 
kinase CHEK1, by TDM correlated with increased cell density in macrophage cultures. Our 
observation that macrophage survival/growth is induced MINCLE-independently by several 
TDM-related glycolipids after 24h, but MINCLE-dependently further enhanced by the cord 
factor after 48h, suggests that both pathways contribute to TDM-induced macrophage growth 
and survival. Phosphorylation of lamins, such as of LMNA observed here, contributes to 
regulation of the cell cycle (73). Thus, these data suggest that TDM promotes the survival 
and/or proliferation of macrophages and may thereby contribute to the dynamics of the 
granuloma response during mycobacterial infection. The concurrent activation of a DNA-
damage response signature is at present unexplained, but may be caused by the action of 
genotoxic substances like ROS and NO generated after stimulation with TDM, or could be a 
consequence of ATR activation due to replication stress. Recently, MYC-dependent DNA-
damage response signaling was shown to be triggered in macrophages infected with M. 
bovis BCG, leading to the formation of multi-nucleated, polyploid macrophages through 
modified cell division (74). This pathway was MYD88-dependent and could be triggered by 
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chronic stimulation with a bacterial lipopeptide TLR2 ligand (74). We have not determined 
whether the cell cycle/DNA-damage response observed here after TDM stimulation also 
leads to generation of multi-nucleated macrophages, but the similarity in the Myc-induction 
and ATM/ATR activity clearly suggests this possibility.     
    
Taken together, we presented in this manuscript the first combined global analysis of the 
macrophage response to a C-type lectin receptor ligand at the phosphoproteome and 
transcriptome level. Our unbiased phosphoproteomic investigation of macrophage activation 
by the mycobacterial cord factor revealed many novel regulated phosphoproteins as 
components of MINCLE-dependent and –independent signaling, which appear to affect 
different biological processes and cellular components. The targeting of phagolysosomal and 
transport phosphoproteins by TDM-MINCLE signaling points to a role in the mycobacteria-
macrophage interaction that merits further investigation. Likewise, the identification of robust 
AKT activation by TDM-MINCLE signaling and the essential role of p85?-PI3K in this process 
and its downstream effects indicate an important role of this pathway in macrophage 
reprogramming during mycobacterial infection. The strong MINCLE-independent component 
of the global phosphorylation and transcriptional response was consistently characterized by 
alterations in cell cycle regulators and DNA-damage response genes. While it remains to be 
clarified by which receptor and mechanism this MINCLE-independent TDM effect is brought 
about, it appears to constitute a significant aspect of macrophage reprogramming by the cord 
factor and resembles recently reported features of mycobacteria-induced macrophage 
phenotypical changes.   
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Figure Legends 
 
Figure 1: TDM/TDB-induced kinase phosphorylation and cytokine expression. 
BMM from WT and Mincle-/- mice were primed with LPS (10 ng/ml) over night, harvested and 
washed, and then transferred for stimulation to cell culture plates coated with 2 μg/ml TDM 
(A, C), or 5 μg/ml TDB (B, D), and isopropanol (ISO) as solvent control. Cells and 
supernatants were harvested at the indicated time points. (A; B) Phosphorylation of SYK, 
ERK and p38 was analyzed by Western blot. (C; D) G-CSF and TNF were analyzed by 
ELISA. Mean+SD. n = 3 
 
Figure 2: Phosphoproteome analysis of macrophages stimulated with TDM. 
(A) For the phosphoproteome analysis we used LPS-primed macrophages from WT and 
MINCLE-deficient mice and stimulated them with plate-coated TDM or ISO solvent control for 
45 min. After cell lysis the proteins were reduced, alkylated and digested with trypsin. Then 
the peptide samples from experimental conditions to be directly compared were labeled with 
light or heavy formaldehyde and mixed together before further processing. Phosphopeptides 
were fractionated and enriched by HILIC and titanium-dioxide beads, and analyzed by LC-
MS/MS. (B) Total numbers of phosphopeptides and phosphoproteins identified. (C) Relative 
frequencies of phosphorylated serine, threonine and tyrosine residues. (D) Volcano plots 
showing phosphosite regulation by TDM treatment of WT macrophages (left panel) and 
comparison of TDM-treated WT and MINCLE-deficient macrophages (right panel). 
Significantly regulated phosphopeptides (p<0.05, ?log2(fold change)?>0.58) are indicated by 
orange and blue boxes.   
 
Figure 3: Mincle-dependence of TDM-induced protein phosphorylation. 
(A) Heatmap of regulated phosphopeptides WT and Mincle-/- macrophages (significantly 
regulated in TDM vs. ISO; p<= 0.05). 
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(B) Histogram of TDM-upregulated phosphorylation sites in WT and Mincle-/- macrophages  
(TDM vs. ISO fc>=1.5 and p<=0.05). Red bars show distribution of fold changes for the TDM 
vs. ISO comparison in WT macrophages; blue bars for the comparison WT vs. MINCLE-
deficient macrophages after stimulation with TDM.   
(C, D) Bioinformatic analysis of MINCLE-dependent and -independent phosphoproteins 
using InnateDB.  The MINCLE-dependent group was defined as TDM vs. ISO fc>=1.5 
p<=0.05 and WT vs. Mincle-/- fc>=1.5 (300 phosphorylation sites / 226 phosphoproteins). The 
MINCLE-independent group was defined as TDM vs. ISO fc>=1.5 p<=0.05 and WT vs. 
Mincle-/- fc<=1.25 (396 phosphorylation sites / 311 phosphoproteins). (C) GO term 
enrichment. (D) Pathway enrichment analysis.  
 
Figure 4: Graphical overview of the phosphoproteome dataset. 
Overview of MINCLE-dependently and -independently phosphorylated proteins after 
stimulation with TDM for 45 min. Summarized hotspots of TDM-induced phosphorylation at 
the level of pathways, biological processes and cellular components. Proteins depicted in 
orange are phosphorylated dependent on MINCLE whereas proteins depicted in blue are 
MINCLE-independently phosphorylated. The proteins depicted in grey have MINCLE-
dependently and -independently regulated phosphorylation sites. The non-filled proteins 
could be detected in the phosphoproteome but they are not regulated by TDM.  
 
Figure 5: Activation of PI3K-AKT signaling by TDM.  
(A) Phosphorylation of AKT on T308 and S473 by TDM and TDB. Stimulation of LPS-primed 
BMM for 1h with TDM, TDB or CpG. (B) Phosphorylation of AKT is MINCLE-dependent. 
Stimulation of LPS-primed BMM with TDM for indicated time points in C57BL/6 or Mincle-/- 
mice. (C) Cytokine production and NO release were analyzed from TDM-stimulated or non-
stimulated BMM which are simultaneously treated with AKT inhibitor Triciribine or AKT 
Inhibitor VIII (n=3). (D) Reduced TDM-induced AKT phosphorylation in PI3K p85?-/- BMM 
compared to WT. Analysis of AKT phosphorylation after 1h stimulation with TDM or CpG in 
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LPS-primed and after 4h stimulation in non-LPS-primed WT and p85?-/- macrophages. (E) 
Reduced TDM-induced cytokine (48h, +LPS) and NO (48h, +IFN?) levels in p85?-/- BMM 
compared to WT (2 independent experiments with 2 mice each per genotype). (F) Gene 
expression analyzed by RT-qPCR of LPS-primed BMM stimulated with TDM or CpG for 24h. 
n = 5 mice pooled from 3 independent experiments. n.s. = not significant. 
 
Figure 6: RNAseq of TDM-induced macrophage activation. 
(A) Hierarchical clustering of differentially expressed genes. (B) Numbers of differentially 
expressed genes: TDM-induced genes (Log2FC (Wt_TDM/Wt_mock)>1.58, adj. p-
value<0.05), TDM-repressed genes (Log2FC (Wt_TDM/Wt_mock)<-1.58, adj. p-value<0.05); 
MINCLE-dependent: Log2 FC (Wt_TDM/Mincle-/-_TDM) > 1.5 / < -1.5, and MINCLE-
independent: Log2FC (Wt_TDM/Mincle-/-_TDM) < 1 / >  -1. (C) K-means clustering showing 
separation in MINCLE-dependent and –independent TDM target genes. (D) selected GO and 
pathway terms enriched in different clusters.  
 
Figure 7: Validation RNAseq data for MINCLE-dependent and –independent gene 
expression.  
(A-C) WT and Mincle-/- BMM were stimulated with TDM or CpG for 24h and gene expression 
was analyzed by qRT-PCR. (A) Csf3 and Nos2 (MINCLE-dependent clusters 1 and 8). (B) 
Ccl22 and Ccr1 from cluster 4. (C) Ccl2 and Nox1 from cluster 6. n=4 from 2 independent 
experiments. (D) CCL2 protein in supernatants of macrophages stimulated for 48h. 
Mean+SD. n=5 from 3 independent experiments. n.s. = not significant. (E-H) Induction of 
gene expression by trehalose monoesters (TMX) and diesters (TDX) with C12 and C16 acyl 
chains, and by the fatty acid (FA) behenate (C22). (E) Csf3, (F) Dusp5, (G) Nox1, (H) Ccl2. 
Mean and SEM, n=5-6 mice, pooled from 3 independent experiments. * p<0.05 WT vs. 
Mincle-/-; # p<0.05 treatment vs. mock in WT BMM. All other responses to identical stimuli 
were not significantly different between WT and Mincle-/- BMM.  
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Figure 8: Cell cycle-associated gene expression is MINCLE-independent. 
(A) WT and Mincle-/- BMM were stimulated for 24h as indicated with TDM, TDB, the trehalose 
monoesters (TMX) and diesters (TDX) with C12 and C16 acyl chains, and the fatty acid (FA) 
behenate (C22). Gene expression of Ccne1, Ccne2, Chek1 and Myc was then analyzed by 
qRT-PCR.  Mean and SEM, n=5-6 mice, pooled from 3 independent experiments. * p<0.05 
WT vs. Mincle-/-; # p<0.05 treatment vs. mock in WT BMM. All other responses to identical 
stimuli were not significantly different between WT and Mincle-/- BMM.  (B)  BCA assay for 
analysis of cellular protein content in BMM cultures stimulated for the indicated times with 
TDM, TDB or CpG ODN 1826. Pooled from four experiments. (C) MTT conversion assay 
from BMM stimulated for 48h. Mean and SEM, n=5-6 mice, pooled from 3 independent 
experiments. * p<0.05 WT vs. Mincle-/-; # p<0.05 treatment vs. mock in WT BMM.   
   
 
 
Figure 1: TDM/TDB-induced kinase phosphorylation and cytokine expression 
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Figure 2: Phosphoproteome analysis of macrophages stimulated with TDM. 
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Figure 3: MINCLE-dependence of TDM-induced protein phosphorylation. 
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Figure 4: Graphical overview of the phosphoproteome dataset 
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Figure 5: Activation of PI3K-AKT signaling by TDM.  
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Figure 6: RNAseq of TDM-induced macrophage activation.  
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Figure 7: Validation RNAseq data for Mincle-dependent and –independent gene expression. 
A 
B 
C 
D 
E 
F 
G 
H 
Nox1
iso C22 C12 C16 C12 C16 TDBTDM
0
5
10
15
20
25
fo
ld
 c
ha
ng
e
Dusp5
iso C22 C12 C16 C12 C16 TDBTDM
0
1
2
3
4
5
6
7
fo
ld
 c
ha
ng
e
Csf3
iso C22 C12 C16 C12 C16 TDBTDM
0
2000
4000
6000
8000
fo
ld
 c
ha
ng
e
Ccl2
iso C22 C12 C16 C12 C16 TDBTDM
0
5
10
15
20
25
40
50
60
fo
ld
 c
ha
ng
e
TMX TDX FA 
TMX TDX FA 
TMX TDX FA 
TMX TDX FA 
* * *
* 
* * 
* 
? ? ? 
? ? ? ? ? 
? ? ? ? ? 
? 
? ? ? ? ? 
? 
? 
? 
? 
C 
B 
Figure 8: Cell cycle-associated gene expression is MINCLE-independent. 
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